JK

John Kelly

Atomo Diagnostics Limited | Chief Executive Officer, Managing Director, Interim Chairman
Mr Kelly is an executive and company director with experience in the medical device industry, from ideation to advanced manufacturing and regulatory approval. He also spent five years at ResMed managing the New Product Implementation Group and helping develop the breakthrough Activa and Swift mask systems.

Companies and Roles

Company
Title
Tenure
Since
AT1
AT1
Atomo Diagnostics Limited
  • Chief Executive Officer
  • Managing Director
  • Interim Chairman
16yrs, 3mthApr 2010
TTX
TTX
Tetratherix Limited
  • Non-Executive Director
1yrs, 1mthMay 2025

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TTX
TTX
Tetratherix Limited
30/06/258,680N/AN/AN/A
AT1
AT1
Atomo Diagnostics Limited
30/06/258,991,87065,120,0001,621,622N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AT1
AT1
Atomo Diagnostics Limited
27/06/25
Issued
1,621,622$0.018$30,000Issue of securities
AT1
AT1
Atomo Diagnostics Limited
27/06/25
Issued
1,621,622$0.015$24,324Issue of securities
AT1
AT1
Atomo Diagnostics Limited
14/04/25
Expiry
666,666$0.022$14,666Options expired
AT1
AT1
Atomo Diagnostics Limited
03/08/23
Expiry
666,666$0.030$19,999Options expired
AT1
AT1
Atomo Diagnostics Limited
27/10/22
Issued
666,666$0.020$13,333Issue of options